Oligoastrocytoma historical perspective

Revision as of 21:02, 15 October 2015 by Sujit Routray (talk | contribs) (Created page with "__NOTOC__ {{Oligoastrocytoma}} {{CMG}}{{AE}}{{SR}} ==Overview== The term "oligodendroglioma" was first coined by Bailey and Cushing in 1926 following the observation that the...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Oligoastrocytoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Oligoastrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Oligoastrocytoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Oligoastrocytoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Oligoastrocytoma historical perspective

CDC on Oligoastrocytoma historical perspective

Oligoastrocytoma historical perspective in the news

Blogs on Oligoastrocytoma historical perspective

Directions to Hospitals Treating Glioma

Risk calculators and risk factors for Oligoastrocytoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

The term "oligodendroglioma" was first coined by Bailey and Cushing in 1926 following the observation that the tumor cells are morphologically similar to oligodendrocytes.[1] Oligodendroglioma was first described and published by W. E. Carnegie Dickson in 1926.[2] In 2009, NJDS mutation was first identified in the pathogenesis of oligodendroglioma by Kevin Smith. Irradiation of pituitary adenoma was also discovered to be associated with oligodendroglioma by Kevin Smith et al.[3]

Historical Perspective

  • The term "oligodendroglioma" was first coined by Bailey and Cushing in 1926 following the observation that the tumor cells are morphologically similar to oligodendrocytes.[1]
  • Oligodendroglioma was first described and published by W. E. Carnegie Dickson in 1926.[2]
  • Their name is derived from the Greek words "oligo" meaning few and "dendro" meaning trees.
  • In 2009, Kevin Smith was the first to discover the association between NJDS mutation and development of oligodendroglioma.[3]
  • Irradiation of pituitary adenoma was also discovered to be associated with oligodendroglioma by Kevin Smith et al.

References

  1. 1.0 1.1 Hartmann C, von Deimling A (2009). "Molecular pathology of oligodendroglial tumors". Recent Results Cancer Res. 171: 25–49. doi:10.1007/978-3-540-31206-2_2. PMID 19322536.
  2. 2.0 2.1 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID http://dx.doi.org/10.1093/brain/49.4.578 Check |pmid= value (help).
  3. 3.0 3.1 Etiology of oligodendroglioma. Wikipedia. https://en.wikipedia.org/wiki/Oligodendroglioma


Template:WikiDoc Sources